GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 152,700
-1,000 (-0.65%)
At close: Jul 25, 2025, 3:30 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.74 trillion as of July 25, 2025. Its market cap has increased by 34.42% in one year.
Market Cap
1.74T
Enterprise Value
2.92T
Revenue
1.71T
Ranking
n/a
PE Ratio
60.67
Stock Price
152,700.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.74T, an increase of 5,891.91%. That is a compound annual growth rate of 14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 1,742.79B | -14.93% |
| Dec 30, 2024 | 2,048.67B | 43.03% |
| Dec 28, 2023 | 1,432.35B | -3.09% |
| Dec 29, 2022 | 1,478.01B | -40.60% |
| Dec 30, 2021 | 2,488.07B | -46.31% |
| Dec 30, 2020 | 4,633.75B | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.87T |
| Celltrion | 39.84T |
| ALTEOGEN | 24.69T |
| Yuhan | 9,219.06B |
| SK Biopharmaceuticals | 7,987.95B |
| Peptron | 6,663.04B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 6,015.61B |